Section 1: Lung Cancer Control and Epidemiology

1. Classical Epidemiology

2. Tobacco Control and Primary Prevention

3. Tobacco Cessation

4. Non-Smoking Related Lung Cancer

5. Gender-Related Differences in Lung Cancer

6. Genetic Susceptibility to Lung Cancer

7. Early Detection and Radiologic Screening

8. Preclinical Biomarkers for The Early Detection of Lung Cancer

9. Chemoprevention of Lung Cancer: Present and Developing Technologies

Section 2: Lung Cancer Molecular Carcinogenesis

1. Copy Number Abnormalities and Gene Rearrangements in Lung Cancer: Present and Developing Technologies

2. Mutational Events in Lung Cancer: Present and Developing Technologies

3. Epigenetic Events, Alterations, and Remodeling in Lung Cancer: Present and Developing Technologies

4. Stem Cells and Lung Cancer: In Vitro and In Vivo Studies

5. Microenvironment and Lung Cancer

6. MicroRNAs as Biomarkers for Lung Cancer

Section 3: Immunology

1. Humoral and Cellular Immune Dysregulation and Lung Cancer

Section 4: Pathology

1. Classic Anatomic Pathology and Lung Cancer

2. Molecular Testing and Lung Cancer

3. Management of the Small Biopsy in the Molecular Er

Section 5: Clinical and Radiologic Presentation of Lung Cancer

1. Clinical Presentation

2. Conventional Imaging Lung Cancer

3. PET Imaging of Lung Cancer

Section 6: Diagnosis and Staging of Lung Cancer

1. Diagnostic Work-Up of Suspected Lung Cancer

2. Surgical Staging of the Mediastinum including Mediastinoscopy and Thoracoscopy, Preoperative and Intraoperative

3. The 8th Edition of the Tumor, Node and Metastasis Classification of Lung Cancer

Section 7: Surgical Management of Lung Cancer

1. Preoperative Functional Evaluation of the Surgical Candidate

2. Results of Video Assisted Techniques for Resection of Lung Cancer

3. Results of Robotic Techniques for Resection of Lung Cancer

4. Extent of Surgical Resection for Stage I and II Lung Cancer

5. Extended Resections for Lung Cancer: Chest Wall and Pancoast Tumors

6. Extended Resections for Lung Cancer: Broncho/Vascular Sleeve Resections

7. Multiple Nodules: Management of the Patient with Synchronous or Metachronous Lung Cancers

8. Surgical Management of the Marginally Resectable Patient

Section 8: Radiotherapeutic Management of Lung Cancer

1. Technical Requirements for Lung Cancer Radiotherapy

2. Radiobiology of Lung Cancer

3. Patient Selection for Radiotherapy

4. Stage I Non-Small Cell Lung Cancer and Oligometastatic Disease

5. Ablation Options for Localized Lung Cancer

6. Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer, including Combined Modality

7. Radiotherapy in the Management of Small Cell Lung Cancer: Thoracic Radiotherapy, Prophylactic Cranial Irradiation

8. Palliative Radiotherapy for Lung Cancer: Locoregional and Metastatic

9. Acute and Late Toxicities of Thoracic Radiotherapy: Pulmonary, Esophagus, Heart

10. Treatment-Related Neurotoxicity, Medical and Radiation Therapy

Section 9: Chemotherapy and Targeted Agents for Lung Cancer

1. Front-Line Systemic Options in Non-Small Cell Lung Cancer

2. Systemic Options in Second Line and Beyond

3. Maintenance Therapy in NSCLC

4. Pharmacogenomics and Lung Cancer

5. New Targetable Pathways in Lung Cancer

6. Management of Toxicities of Targeted Therapies

7. Immunotherapy and Lung Cancer

8. Systemic Therapy in Early-Stage NSCLC

9. Treatment of Small-Cell Lung Cancer

Section 10: Other Thoracic Malignancies

1. Malignant Mesothelioma

2. Mediastinal Tumors

3. Neuroendocrine Tumors of the Lung Other than SCLC

4. Thymic Cancer/Thymoma

Section 11: Symptom Management and Complications

1. Lung Cancer Emergencies

2. Role of Palliative Care in Lung Cancer

Section 12: Clinical Trials

1. Methodology of Clinical Trials in Lung Cancer

2. How to Promote